1. Home
  2. Publications
  3. Publications of type "Paper"

Publications of type "Paper"

Enter any text in the title of the paper (e.g. 'Breast'; 'Scotland')
The full UKIACR member associated with this publication

  1. National comparisons of lung cancer survival in England, Norway and Sweden 2001-2004: differences occur early in follow-up.

    Holmberg L, Sandin F, Bray F, Richards M, Spicer J, Lambe M, Klint A, Peake M, Strand TE, Linklater K, Robinson D, Møller H
    Thorax. 2010 May; 65(5):436-41. PMID: 20435867

  2. Trends in skin cancer incidence by socioeconomic position in Scotland, 1978-2004.

    Doherty VR, Brewster DH, Jensen S, Gorman D
    Br J Cancer. 2010 May 25; 102(11):1661-4. PMID: 20442712

  3. Oropharyngeal cancer. Fastest increasing cancer in Scotland, especially in men.

    Junor EJ, Kerr GR, Brewster DH
    BMJ. 2010 May 11; 340:c2512. PMID: 20460323

  4. Survival from twenty adult cancers in the UK and Republic of Ireland in the late twentieth century.

    Woods LM, Rachet B, Shack L, Catney D, Walsh PM, Cooper N, White C, Mak V, Steward J, Comber H, Gavin A, Brewster D, Quinn M, Coleman MP
    Health Stat Q. 2010 Summer; (46):5-24. PMID: 20531364

  5. Population based time trends and socioeconomic variation in use of radiotherapy and radical surgery for prostate cancer in a UK region: continuous survey.

    Lyratzopoulos G, Barbiere JM, Greenberg DC, Wright KA, Neal DE
    BMJ. 2010 Apr 21; 340:c1928. PMID: 20413566

  6. Trends in prostate specific antigen testing in Ireland: lessons from a country without guidelines.

    Drummond FJ, Carsin AE, Sharp L, Comber H
    Ir J Med Sci. 2010 Mar; 179(1):43-9. PMID: 19562407

  7. Reduced risk of oestrogen receptor positive breast cancer among peri- and post-menopausal women in Scotland following a striking decrease in use of hormone replacement therapy.

    Sharpe KH, McClements P, Clark DI, Collins J, Springbett A, Brewster DH
    Eur J Cancer. 2010 Mar; 46(5):937-43. PMID: 20122823

  8. Distribution of HPV types associated with cervical cancers in Scotland and implications for the impact of HPV vaccines.

    Cuschieri K, Brewster DH, Williams AR, Millan D, Murray G, Nicoll S, Imrie J, Hardie A, Graham C, Cubie HA
    Br J Cancer. 2010 Mar 2; 102(5):930-2. PMID: 20145611

  9. Prevalence of esophageal cancer risk factors among Turkmen and non-Turkmen ethnic groups in a high incidence area in Iran.

    Marjani HA, Biramijamal F, Hossein-Nezhad A, Islami F, Pourshmas A, Semnani S
    Arch Iran Med. 2010 Mar; 13(2):111-5. PMID: 20187664

  10. Trends in the incidence and survival of multiple myeloma in South East England 1985-2004.

    Renshaw C, Ketley N, Møller H, Davies EA
    BMC Cancer. 2010 Mar 1; 10:74. PMID: 20193064

  11. Waiting times for radiotherapy after breast cancer.

    Jack RH, Holmberg L
    BMJ. 2010 Mar 2; 340:c1007. PMID: 20197324

  12. Long-term outcomes of breast cancer in women aged 30 years or younger, based on family history, pathology and BRCA1/BRCA2/TP53 status.

    Evans DG, Moran A, Hartley R, Dawson J, Bulman B, Knox F, Howell A, Lalloo F
    Br J Cancer. 2010 Mar 30; 102(7):1091-8. PMID: 20234365

  13. Estimating attendance for breast cancer screening in ethnic groups in London.

    Renshaw C, Jack RH, Dixon S, Møller H, Davies EA
    BMC Public Health. 2010 Mar 25; 10:157. PMID: 20334699

  14. Life course social mobility and risk of upper aerodigestive tract cancer in men

    Schmeisser N, Conway DI, McKinney PA, McMahon AD, Pohlabeln H, Marron M, Benhamou S, Bouchardy C, Macfarlane GJ, Macfarlane TV, Lagiou P, Lagiou A, Bencko V, Holcátová I, Merletti F, Richiardi L, Kjaerheim K, Agudo A, Talamini R, Polesel J, Canova C, Simonato L, Lowry R, Znaor A, Healy C, McCarten BE, Hashibe M, Brennan P, Ahrens W
    Eur J Epidemiol. 2010 Mar; 25(3):173-82. Epub 2010 Feb 9 PMID: 20143252

  15. Risks of second primary cancer among patients with major histological types of lung cancers in both men and women

    Chuang SC, Scélo G, Lee YC, Friis S, Pukkala E, Brewster DH, Hemminki K, Tracey E, Weiderpass E, Tamaro S, Pompe-Kirn V, Kliewer EV, Chia KS, Tonita JM, Martos C, Jonasson JG, Boffetta P, Brennan P, Hashibe M
    Br J Cancer. 2010 Mar 30; 102(7):1190-5 PMID: 20354532

  16. Improved malignant melanoma prognosis at a consultant-delivered multidisciplinary pigmented lesion clinic in Cork.

    Field S, Deady S, Fitzgibbon J, Murphy M, Comber H
    Ir Med J. 2010 Feb; 103(2):40-3. PMID: 20666053

  17. Cohort Profile: The Golestan Cohort Study--a prospective study of oesophageal cancer in northern Iran.

    Pourshams A, Khademi H, Malekshah AF, Islami F, Nouraei M, Sadjadi AR, Jafari E, Rakhshani N, Salahi R, Semnani S, Kamangar F, Abnet CC, Ponder B, Day N, Dawsey SM, Boffetta P, Malekzadeh R
    Int J Epidemiol. 2010 Feb; 39(1):52-9. PMID: 19332502

  18. Modelling relative survival in the presence of incomplete data: a tutorial.

    Nur U, Shack LG, Rachet B, Carpenter JR, Coleman MP
    Int J Epidemiol. 2010 Feb; 39(1):118-28. PMID: 19858106

  19. The relationship between hospital volume and post-operative mortality rates for upper gastrointestinal cancer resections: Scotland 1982-2003.

    Skipworth RJ, Parks RW, Stephens NA, Graham C, Brewster DH, Garden OJ, Paterson-Brown S
    Eur J Surg Oncol. 2010 Feb; 36(2):141-7. PMID: 19879717

  20. SOX9 elevation in the prostate promotes proliferation and cooperates with PTEN loss to drive tumor formation.

    Thomsen MK, Ambroisine L, Wynn S, Cheah KS, Foster CS, Fisher G, Berney DM, Møller H, Reuter VE, Scardino P, Cuzick J, Ragavan N, Singh PB, Martin FL, Butler CM, Cooper CS, Swain A
    Cancer Res. 2010 Feb 1; 70(3):979-87. PMID: 20103652